Andere Sprachen Ardelyx, Inc.

Aktien

A116X0

US0396971071

ARDX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
6,42 ^USD	+1,74 %		-0,93 %	+3,55 %

17.04.	ARDELYX, INC. : erhält Kaufen-Rating von Wedbush	ZM
05.04.	ARDELYX, INC. : Leerink Partners bleibt bei seiner Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024	18.04.
Ardelyx, Inc. Reports Employment Inducement Grants	28.03.
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	25.03.
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	25.03.
Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy	25.03.
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing	22.03.
Ardelyx, Inc. Reports Employment Inducement Grants	12.03.
Ardelyx, Inc. Reports Employment Inducement Grants	12.03.
Ardelyx, Inc. announced that it has received $50 million in funding	05.03.
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28.02.
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference	27.02.
Sector Update: Health Care Stocks Mixed Premarket Friday	23.02.
Sector Update: Health Care	23.02.
Ardelyx's Q4 Swings to Loss; Revenues Down; Shares Down After-Hours	23.02.
Ardelyx: Q4 Earnings Snapshot	22.02.
Ardelyx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
Earnings Flash (ARDX) ARDELYX Posts Q4 Revenue $34.4M, vs. Street Est of $34.2M	22.02.
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	22.02.
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ardelyx, Inc.

Aktien

A116X0

US0396971071

ARDX

Andere Sprachen

Filter